JULIE HANEY: Open Payments
NPI 1679996805 · ATHENS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$307 in 16 payments from 11 companies in 2025. Trend: 2023 $562 · 2024 $568 · 2025 $307
Food & beverage: $307
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $46 |
| PFIZER INC. | 2 | $42 |
| ABBVIE INC. | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Abbott Laboratories | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Exact Sciences Corporation | 1 | $15 |
Products named: REPATHA, ELIQUIS, VRAYLAR, SHINGRIX, FREESTYLE LIBRE 3, XIFAXAN, GVOKE HYPOPEN, Wegovy.
Industry payments across TN — which companies pay providers there.
